drugset / Trial / NCT06570538
Analgesic Efficacy of an Opioid-free Postoperative Pain Management Strategy Versus a Conventional Opioid-based Strategy Following Video-assisted Thoracoscopic Lobectomy
Phase 0
Not yet recruiting
140 enrolled
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
RandomizedParallel-groupOpen-labelTreatment
Summary
Investigators have designed a randomized controlled trial. Utilizing an open-label, randomized, controlled study methodology, this trial aims to explore a opioid-free, safe, and effective analgesic approach for thoracic surgery. It also seeks to provide clinical guidance for the implementation of opioid-free or reduced-opioid postoperative analgesia in other thoracic procedures, aiming to optimize postoperative pain management for patients and ultimately enhance the overall patients recovery experience.
Timeline
- Start
- 2024-09-01
- Primary completion
- 2025-05-31
- Completion
- 2025-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ropivacaine | Other / unclassified | 0.25 % | Other |
| Comparator | Sufentanil | Other / unclassified | 2 ug/kg | Intravenous |
Indications
No indication recorded.